ANAPTYSBIO, INC. (ANAB) Free cash flow 2016–2025
ANAPTYSBIO, INC. (ANAB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$19.6MFY2025 · since FY2016: -$9.1M → $19.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $19.6M | +114.5% |
| FY2024 | -$135.7M | -11.6% |
| FY2023 | -$121.6M | -64.4% |
| FY2022 | -$74.0M | -56.4% |
| FY2021 | -$47.3M | -221.1% |
| FY2020 | -$14.7M | +79.1% |
| FY2019 | -$70.3M | -41.9% |
| FY2018 | -$49.6M | -151.3% |
| FY2017 | -$19.7M | -117.3% |
| FY2016 | -$9.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice